Efficacy of treatments for VIPoma: A GTE multicentric series.
Fiche publication
Date publication
août 2021
Journal
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Auteurs
Membres identifiés du Cancéropôle Est :
Pr CADIOT Guillaume, Pr LEPAGE Côme
Tous les auteurs :
Brugel M, Walter T, Goichot B, Smith D, Lepage C, Cao CD, Hautefeuille V, Rebours V, Cadiot G, de Mestier L,
Lien Pubmed
Résumé
Vasoactive intestinal peptide-secreting tumor (VIPoma) is a very rare, life-threatening, functioning pancreatic neuroendocrine tumor (pNET). The efficacy of antitumor therapies against functioning symptoms and tumor burden have been poorly described in VIPoma.
Mots clés
Diarrhea, Neuroendocrine tumor, Survival, Treatment, Vipoma
Référence
Pancreatology. 2021 Aug 5;: